Page last updated: 2024-10-24

chlorambucil and Thoracic Neoplasms

chlorambucil has been researched along with Thoracic Neoplasms in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Thoracic Neoplasms: New abnormal growth of tissue in the THORAX.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BIERMAN, HR1
Stern, OS1
Tulgan, H1
Budnitz, J1
Haidak, G1

Other Studies

2 other studies available for chlorambucil and Thoracic Neoplasms

ArticleYear
The chemotherapy of intrathoracic tumors.
    Diseases of the chest, 1962, Volume: 42

    Topics: Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Humans; Mechlorethamine; Methotrexate; Neopl

1962
Endobronchial presentation of malignant lymphoma.
    The American review of respiratory disease, 1968, Volume: 98, Issue:5

    Topics: Bone Neoplasms; Bronchial Neoplasms; Bronchoscopy; Chlorambucil; Hodgkin Disease; Humans; Male; Mech

1968